NCT03070236View on ClinicalTrials.gov

PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions

NAActive, not recruitingINTERVENTIONAL
Enrollment

912

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

May 27, 2019

Study Completion Date

February 25, 2030

Conditions
Breast Cancer
Interventions
OTHER

Survey

Select questions will be ask in the survey

Trial Locations (6)

27710

Duke University Medical Center, Durham

77030

MD Anderson Cancer Center, Houston

02114

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

02462

Newton-Wellesley Hospital, Newton

02198

Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, Weymouth

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER